Enterprise AI Analysis: Medical Devices
Microfluidic automation improves oocyte recovery from follicular fluid of patients undergoing in vitro fertilization
A novel microfluidic device (FIND-Chip) automates oocyte isolation and denudation from follicular fluid (FF) in IVF, revealing that over 50% of functional oocytes are routinely discarded. Clinical studies show FIND-Chip recovers these missed oocytes, leading to high-quality blastocysts and a live birth. This automation significantly expands the embryo pool, potentially increasing IVF success rates and addressing the persistent demand-access gap.
Key Performance Indicators
Leveraging microfluidic automation to drive significant improvements in IVF success rates and operational efficiency.
0%
Increase in embryo pool
0
Live Birth Achieved
0 min
Per sample processing
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
Automated Oocyte Recovery
The FIND-Chip automates the critical step of isolating and denuding oocytes from follicular fluid (FF) in IVF workflows. This process, traditionally manual and laborious, is now standardized and made more efficient.
582
Patients in Clinical Study
Uncovering Discarded Oocytes
A significant finding is that over 50% of functional and mature oocytes are inadvertently discarded under current manual clinical practice. The FIND-Chip successfully recovers these previously missed oocytes.
| Manual Screening | FIND-Chip Recovery |
|---|---|
|
|
Enhanced Embryo Pool & Live Births
The recovered oocytes successfully developed into high-quality blastocysts, substantially expanding the embryo pool. Notably, an oocyte retrieved by FIND-Chip from a discarded FF sample led to a live birth.
Enterprise Process Flow
Clinical FF collected
→
Manual screening (discarded FF)
→
FIND-Chip processes discarded FF
→
Extra oocytes recovered
→
High-quality blastocysts
→
Increased embryo pool for patients
→
Live Birth achieved
Impact on IVF Success Rates
Microfluidic automation has the potential to significantly enhance IVF success rates by ensuring the recovery of all available viable oocytes. This addresses a critical need in infertility treatment, especially for patients with low oocyte yield.
10.2%
Overall Increase in Oocyte Pool
Calculate Your IVF Clinic's Potential ROI with FIND-Chip
Estimate the economic and operational benefits of automating oocyte recovery in your clinic. Increased oocyte yield directly translates to higher success rates and patient satisfaction.
Estimated Annual Savings
$0
Embryologist Hours Reclaimed Annually
0
FIND-Chip Implementation Roadmap
A phased approach to integrate automated oocyte recovery into your IVF clinic workflow, maximizing efficiency and patient outcomes.
Phase 1: Initial Assessment & Setup
Clinic evaluation, device installation, staff training, and initial calibration with non-patient samples. (Estimated: 2-4 weeks)
Phase 2: Pilot Clinical Integration
Introduction of FIND-Chip for supplementary oocyte recovery on discarded FF, closely monitoring initial patient outcomes and system performance. (Estimated: 4-8 weeks)
Phase 3: Full Workflow Integration
Seamless integration of FIND-Chip into the primary oocyte retrieval workflow, optimizing for efficiency and maximum oocyte yield. (Estimated: 8-12 weeks)
Phase 4: Ongoing Optimization & Scaling
Continuous performance review, advanced training, and scaling operations across multiple retrieval rooms or clinics. (Ongoing)
Ready to transform your IVF lab with automation? Schedule a personalized consultation to discuss how FIND-Chip can enhance your clinic's success rates and operational efficiency.
Ready to Get Started?
Book Your Free Consultation.
Let's Discuss Your AI Strategy!
Lets Discuss Your Needs
Select a Date
Sun
Mon
Tue
Wed
Thu
Fri
Sat